SCHEMBL14108169

SCHEMBL14108169

Cn1nc(N)cc1C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL894594 0.76 — —
SCHEMBL23851895 0.75 TRIM24 (0.32) —
SCHEMBL15400895 0.74 — —
SCHEMBL2520789 0.74 — —
SCHEMBL20177077 0.74 — —
SCHEMBL17796355 0.74 POLB (0.37) —
SCHEMBL17796356 0.74 POLB (0.37) —
SCHEMBL20757349 0.74 TRIM24 (0.31) —
SCHEMBL2516598 0.72 TRIM24 (0.33) —
SCHEMBL20757758 0.72 CA12 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7417152-B2 4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B1 receptor antagonists for the treatment of inflammatory diseases ELAN PHARMACEUTICALS, INC. (US) 2008-08-26 — — US disclosed
Send feedback